A Brain-Permeable Small Molecule Reduces Neuronal Cholesterol by Inhibiting Activity of Sirtuin 2 Deacetylase
- 9 March 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 6 (6) , 540-546
Abstract
Sirtuin 2 (SIRT2) deacetylase-dependent inhibition mediates neuroprotective reduction of cholesterol biosynthesis in an in vitro Huntington’s disease model. This study sought to identify the first brain-permeable SIRT2 inhibitor and to characterize its cholesterol-reducing properties in neuronal models. Using biochemical sirtuin deacetylation assays, we screened a brain-permeable in silico compound library, yielding 3-(1-azepanylsulfonyl)-N-(3-bromphenyl)benzamide as the most potent and selective SIRT2 inhibitor. Pharmacokinetic studies demonstrated brain-permeability but limited metabolic stability of the selected candidate. In accordance with previous observations, this SIRT2 inhibitor stimulated cytoplasmic retention of sterol regulatory element binding protein-2 and subsequent transcriptional downregulation of cholesterol biosynthesis genes, resulting in reduced total cholesterol in primary striatal neurons. Furthermore, the identified inhibitor reduced cholesterol in cultured naïve neuronal cells and brain slices from wild-type mice. The outcome of this study provides a clear opportunity for lead optimization and drug development, targeting metabolic dysfunctions in CNS disorders where abnormal cholesterol homeostasis is implicated.Keywords
This publication has 18 references indexed in Scilit:
- Cholesterol Defect Is Marked across Multiple Rodent Models of Huntington's Disease and Is Manifest in AstrocytesJournal of Neuroscience, 2010
- SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesisProceedings of the National Academy of Sciences, 2010
- Genome-wide Analysis of Chromatin Regulation by Cocaine Reveals a Role for SirtuinsNeuron, 2009
- Biological and Potential Therapeutic Roles of Sirtuin DeacetylasesCellular and Molecular Life Sciences, 2008
- The regulation of SIRT2 function by cyclin-dependent kinases affects cell motilityJournal of Cell Biology, 2008
- Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's DiseaseScience, 2007
- Mitotic Regulation of SIRT2 by Cyclin-dependent Kinase 1-dependent PhosphorylationJournal of Biological Chemistry, 2007
- Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neuronsNature Genetics, 2005
- A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivoProceedings of the National Academy of Sciences, 2005
- The Human Sir2 Ortholog, SIRT2, Is an NAD+-Dependent Tubulin DeacetylaseMolecular Cell, 2003